Works matching IS 00070920 AND DT 2024 AND VI 130 AND IP 3
Results: 18
Associations of diabetes, circulating protein biomarkers, and risk of pancreatic cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 504, doi. 10.1038/s41416-023-02533-2
- By:
- Publication type:
- Article
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 476, doi. 10.1038/s41416-023-02534-1
- By:
- Publication type:
- Article
Association between weight cycling and risk of colorectal cancer: a prospective cohort study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 496, doi. 10.1038/s41416-023-02529-y
- By:
- Publication type:
- Article
PAK inhibitor FRAX486 decreases the metastatic potential of triple-negative breast cancer cells by blocking autophagy.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 394, doi. 10.1038/s41416-023-02523-4
- By:
- Publication type:
- Article
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 450, doi. 10.1038/s41416-023-02519-0
- By:
- Publication type:
- Article
CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 467, doi. 10.1038/s41416-023-02542-1
- By:
- Publication type:
- Article
Enhanced antitumour response of gold nanostar-mediated photothermal therapy in combination with immunotherapy in a mouse model of colon carcinoma.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 406, doi. 10.1038/s41416-023-02537-y
- By:
- Publication type:
- Article
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 425, doi. 10.1038/s41416-023-02528-z
- By:
- Publication type:
- Article
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 442, doi. 10.1038/s41416-023-02524-3
- By:
- Publication type:
- Article
Correction: Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Factors associated with the melanoma diagnostic interval in Ontario, Canada: a population-based study.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 483, doi. 10.1038/s41416-023-02518-1
- By:
- Publication type:
- Article
Periostin–TGF-β feedforward loop contributes to tumour-stroma crosstalk in liver metastatic outgrowth of colorectal cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 358, doi. 10.1038/s41416-023-02516-3
- By:
- Publication type:
- Article
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 457, doi. 10.1038/s41416-023-02515-4
- By:
- Publication type:
- Article
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 417, doi. 10.1038/s41416-023-02514-5
- By:
- Publication type:
- Article
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 434, doi. 10.1038/s41416-023-02513-6
- By:
- Publication type:
- Article
MET exon 14 skipping mutation drives cancer progression and recurrence via activation of SMAD2 signalling.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 380, doi. 10.1038/s41416-023-02495-5
- By:
- Publication type:
- Article
Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 369, doi. 10.1038/s41416-023-02494-6
- By:
- Publication type:
- Article
Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 347, doi. 10.1038/s41416-023-02485-7
- By:
- Publication type:
- Article